LARGE FAMILY FOR LARGE ACHIEVEMENTS
We develop modern prevention, diagnostics and therapy products for health preservation and improved quality of life.
Press centre
NOTICE/RECONVENING REGULAR ANNUAL ASSEMBLY
NOTICE ON RECONVENING THE REGULAR ANNUAL GENERAL ASSEMBLY OF BOSNALIJEK JSC
Based on the Decision No 2427/23 of 14 June 2023, the Supervisory Board of the Bosnalijek JSC, in accordance with provisions of Article 233 Paragraph 2 to 4 of the Company Law of Federation of BIH and Article 55 Paragraph 2 and 3 of the Statute of Bosnalijek JSC, the Supervisory Board publishes:
MORE
PRESS CENTAR / NEWS
Danish journalists were convinced of the top quality of Bosnalijek
The largest domestic pharmaceutical company, Bosnalijek hosted a group of 16 journalists from Denmark, employees of the magazine "Borzen". Borzen journalists decided to visit Bosnalijek as a part of their trip to Bosnia and Herzegovina.
In detail
PRESS CENTAR / NEWS
Cooperation Agreement Signed between Bosnalijek and Abdi Ibrahim – Bosnalijek’s Products About to E ...
Bosnalijek and Abdi Ibrahim, the largest pharmaceutical companies from Bosnia and Herzegovina and the Republic of Turkey, announced a signing of cooperation agreement in Sarajevo for the placement of Bosnalijek products on the Turkish market.
In detail
Useful Resources
maj 26. 2024 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%